SF3B1 and neoplasm: Although an association of mutated SF3B1 with favourable prognosis was observed in the first few years 122, with longer follow up time, SF3B1 mutant patients developed more metastases and tumours with D3 and SF3B1 mutation showed a significant worse prognosis compared to wild‐type tumours 121, 123